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Abstract: In recent years there has been a growing interest in the biological activity of  
red beetroot (Beta vulgaris rubra) and its potential utility as a health promoting and disease 
preventing functional food. As a source of nitrate, beetroot ingestion provides a natural means 
of increasing in vivo nitric oxide (NO) availability and has emerged as a potential strategy 
to prevent and manage pathologies associated with diminished NO bioavailability, notably 
hypertension and endothelial function. Beetroot is also being considered as a promising 
therapeutic treatment in a range of clinical pathologies associated with oxidative stress and 
inflammation. Its constituents, most notably the betalain pigments, display potent antioxidant, 
anti-inflammatory and chemo-preventive activity in vitro and in vivo. The purpose of this 
review is to discuss beetroot’s biological activity and to evaluate evidence from studies that 
specifically investigated the effect of beetroot supplementation on inflammation, oxidative 
stress, cognition and endothelial function.  
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1. Introduction 
The well-documented health benefits of a diet high in fruit and vegetables has led to a growing interest 
in so-called “functional foods” and their application in health and disease. In recent years, the root 
vegetable Beta vulgaris rubra, otherwise known as red beetroot (herein referred to as beetroot) has 
attracted much attention as a health promoting functional food. While scientific interest in beetroot has 
only gained momentum in the past few decades, reports of its use as a natural medicine date back to Roman 
times [1]. Today, beetroot is grown in many countries worldwide, is regularly consumed as part of the 
normal diet, and commonly used in manufacturing as a food colouring agent known as E162 [2,3]. 
The recent interest in beetroot has been primarily driven by the discovery that sources of dietary nitrate 
may have important implications for managing cardiovascular health [4]. However, beetroot is rich in 
several other bioactive compounds that may provide health benefits, particularly for disorders characterised 
by chronic inflammation. Consequently, the potential role for beetroot as an adjunct treatment in several 
clinical conditions will be presented; Specifically, the aims of this review are twofold: (1) to highlight 
evidence from recent studies showing the physiological and biological actions of beetroot; and (2) to 
evaluate its use as a nutritional intervention in health and disease, with a special emphasis on experimental 
studies relating to oxidative stress, inflammation, endothelial function and cognition. 
Recent studies have provided compelling evidence that beetroot ingestion offers beneficial physiological 
effects that may translate to improved clinical outcomes for several pathologies, such as; hypertension, 
atherosclerosis, type 2 diabetes and dementia [1,5–8]. Hypertension in particular has been the target of 
many therapeutic interventions and there are numerous studies that show beetroot, delivered acutely as 
a juice supplement [9–11] or in bread [12,13] significantly reduce systolic and diastolic blood pressure. 
Further discussion of beetroot’s anti-hypertensive potential is summarised in several reviews: [14–16]. 
Beetroot’s effect on the vasculature is largely attributed to its high inorganic nitrate content (250 mg∙kg−1 
of fresh weight; [17]). Nitrate itself is not considered to mediate any specific physiological function; rather, 
nitrates beneficial effects are attributed to its in vivo reduction to nitric oxide (NO), a multifarious messenger 
molecule with important vascular and metabolic functions [14,18]. The generation of NO via nitrate involves 
a series of sequential steps that have been well described in the literature [4,19]. Briefly, ingested nitrate 
is first absorbed through the upper part of the small intestine into the systemic circulation [4,15]. It is 
then estimated that 25% of the circulating nitrate enters the entero-salivary cycle where bacterial species 
located at the posterior aspect of the tongue bioactivate or reduce salivary nitrate to nitrite [16,19]. Because 
salivary bacteria facilitate the reduction reaction that converts nitrate to nitrite, spitting out saliva or 
taking oral anti-bacterial treatments, like dental mouthwash for example, has been shown to diminish 
nitrate-nitrite conversion [10,18]. Under normal circumstances, however, salivary nitrite is re-absorbed 
into the circulation via the stomach where it is metabolised to NO and other nitrogen oxides by a variety 
of reductase enzymes [4,10,13]. 
However, as previously mentioned, nitrate is not the only constituent of beetroot proposed to have 
beneficial effects in health and disease. Beetroot is a rich source of phytochemical compounds (Figure 1), 
that includes ascorbic acid, carotenoids, phenolic acids and flavonoids [2,20,21]. Beetroot is also one of 
the few vegetables that contain a group of highly bioactive pigments known as betalains [22,23]. Members 
of the betalain family are categorised as either betacyanin pigments that are red-violet in colour or 
betaxanthin pigments that are yellow-orange in colour [1]. A number of investigations have reported 
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betalains to have high antioxidant and anti-inflammatory capabilities in vitro and a variety of in vivo 
animal models [3,23–26]. This has sparked interest in a possible role for beetroot in clinical pathologies 
characterised by oxidative stress and chronic inflammation such as liver disease [1,23], arthritis [27] and 
even cancer [28–31]. 
 
Figure 1. Overview of potentially bioactive compounds in beetroot (based on data from [1,2,20]). 
2. Bioavailability  
For a food component to be considered beneficial for health it must be bioavailable in vivo, that is, 
following ingestion, the active compounds are absorbed through the gastro-intestinal tract and made available 
in the circulation, in sufficient quantities, to be utilized by cells [21,32]. However, in order to reach the 
systemic circulation and exert any salubrious functions, a food component must maintain its molecular 
structure through several phases of digestion that each present a significant metabolic challenge for the 
molecule and affect its eventual rate and extent of absorption [33,34]. It is therefore critically important 
that any alleged health benefit of a food source be firstly verified with well-designed bioavailability 
studies that characterise the extent of its in vivo absorption [34]. In this respect, the bioavailability of both 
inorganic nitrate and the betalains, the major bioactive components of beetroot, have been considered in 
the literature. The high bioavailability of inorganic dietary nitrate is well established and there are reports 
of close to 100% absorption following digestion [35]. The extent to which betalains are absorbed is, 
however, less clear.  
Two studies have directly investigated betalain bioavailability by measuring their appearance in human 
urine after ingesting a single bolus of beetroot juice [36,37]. Kanner et al. [37] identified 0.5%–0.9% of 
the ingested betacyanins (betanin and isobetanin) in volunteer’s urine in the 12 h after consuming 300 mL 
of beetroot juice. This indicates that although in small amounts, betacyanins can be successfully absorbed 
in humans. They also showed that the peak urinary elimination rate of betacyanains (indicative of absorption), 
occurred 2–4 h after ingestion; however, there was a high level of inter-individual variability within this 
time period. Frank et al. [36] reported similar findings while investigating betacyanin bioavailability. 
After providing six healthy participants with 500 mL of beetroot juice, they identified betacyanins in urine 
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at concentrations equivalent to ~0.3% of the ingested dose over a 24 h period. These studies might be 
interpreted to suggest only small level of bioavailability; however, it is important to realise that betacyanins 
are unlikely to be exclusively eliminated via the renal pathway [36] Indeed, the use of urinary excretion 
as a sole indicator of bioavailability has received criticism because it does not account for the biliary and 
circulatory clearance of compounds, thus underestimating true bioavailability [33]. In addition, the extent 
to which betalains are metabolised and structurally transformed to secondary metabolites is yet to be 
characterized, but should be taken into consideration when examining their bioavailability [36]. 
Given these limitations, Tesoriere et al. [38] employed a different approach to investigate the 
bioavailability of betalains. Tesoriere and colleagues developed a simulated in vitro model of the human 
intestinal epithelium using Caco-2 cell monolayers to mimic a functional barrier. This model allowed them 
to examine whether betalains can be absorbed through a functioning intestinal barrier and hence give an 
indication of their bioavailability. They demonstrated that two betalains; betanin and to a greater extent 
indicaxanthin were well absorbed through the simulated model of the intestinal lining (Caco-2 cell monolayer) 
and mostly in their unmetabolised form via paracellular transport. The latter finding is particularly 
important, because it reveals that betalains can be absorbed into the systemic circulation in their unchanged 
form, allowing them to retain their molecular structure and high biological activity [34]. There was some 
evidence that betanin may be absorbed through transcellular transport as well. Nevertheless, it is important 
to note that results from in vitro experiments, even when designed to mimic the biological milieu of the 
human GI tract, do not necessarily translate in vivo, given that several other factors (i.e., first pass metabolism, 
interactions with gut microflora and protease enzyme degradation) have a significant influence on the 
concentration of the nutrient that eventually reaches the circulation [33,34]. 
In addition to the betalain family, other aforementioned plant derived antioxidants have been identified 
in beetroot, including epicatechin, rutin, and caffeic acid [2], which to varying degrees appear to be well 
absorbed and bioavailable in humans [39]. Although, the bioavailability of these compounds and other 
phenolics from beetroot have not been individually determined, there are data describing the bioavailability 
of the total phenolic compounds present in beetroot. Netzel et al. [40] measured the urinary excretion of 
total phenolic substances following a single 500 mL bolus of beetroot juice. They identified ~685 mg of 
phenolic compounds in participant’s urine ≤24 h following beetroot juice ingestion; 97% more than the 
~347 mg identified after consuming water (i.e., basal concentrations). While the relative bioavailability 
from the individual compounds could not be determined, these findings clearly show that beetroots phenolic 
constituents are extremely well absorbed and likely increase beetroot’s in vivo antioxidant power.  
Taken together, the results of the aforementioned studies provide a good base of evidence that beetroot 
is a bioavailable source of bioactive compounds in humans. With that said, further work is still required 
to firstly; elucidate the bioavailability of beetroot’s individual bioactive components and secondly; to 
establish the extent that plasma, biliary and other metabolic pathways contribute to the excretion of these 
components. Together, these data would give a better understanding of beetroots phytochemical 
bioavailability and thus elucidate the potential as a health-promoting intervention for humans. 
3. Oxidative Stress 
Beetroot supplementation might serve as a useful strategy to strengthen endogenous antioxidant 
defences, helping to protect cellular components from oxidative damage. Under normal metabolic 
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conditions, the biological environment of a cell is considered to be in a state of redox balance, or in other 
words, an equilibrium exists between reducing (antioxidants) and oxidising (pro-oxidants) agents [41,42]. 
Molecules capable of oxidation are commonly known as reactive oxygen and nitrogen species (RONS) 
and are continuously generated in cellular metabolism [42]. At these low concentrations, RONS play an 
important role in a diverse multitude of cellular and biochemical processes, including gene expression, 
cell proliferation, apoptosis and muscular contraction [41–44]. However, excess exposure of a cell to 
exogenously generated RONS (UV radiation, xenobiotics) or endogenously synthesised RONS (aberrant 
cell metabolism, inflammation), can overwhelm the cells antioxidant defences, causing an imbalance in 
redox homeostasis, which gives rise to the condition typically referred to as oxidative stress [42]. This 
imbalance may overwhelm the endogenous antioxidant defence network leaving DNA, carbohydrate, 
protein and lipid structures susceptible to oxidation and functional impairments [45–47]. 
In some instances, cells can suffer from acute spells of oxidative stress that temporarily weaken 
antioxidant defences [48]. This can occur through excessive heat exposure, infectious pathogens and 
strenuous physical exercise, which are capable of generating RONS that leave cells vulnerable to 
transient oxidation [44,48]. However, in many human disease states, such as cancer, oxidative stress is 
a chronic disorder perpetuated by continual and excess production of RONS that induce long-term 
cellular disruption [48,49]. A previous estimate [42] suggested that oxidative stress plays a role in the 
pathophysiology of over 200 clinical conditions. It is therefore unsurprising that many antioxidant food 
sources have been evaluated for their ability to scavenge RONS and avert oxidative stress. 
Beetroot is as an exceptionally rich source of antioxidant compounds. The betalain pigments in 
particular, has been shown by several in vitro studies to protect cellular components from oxidative 
injury [37,50,51]. For example, in the study by Kanner et al. [37] two betalain metabolites (betanin and 
betanidin) were shown to reduce linoleate damage induced by cytochrome C oxidase and lipid membrane 
oxidation induced by H2O2-activated metmyoglobin and free iron (AA-Fe). The authors also reported 
that betanin, the most abundant betalain found in beetroot (300–600 mg∙kg−1), was the most effective 
inhibitor of lipid peroxidation. Betanin’s high antioxidant activity appeared to stem from its exceptional 
electron donating capacity and ability to defuse highly reactive radicals targeting cell membranes [37]. 
However, as alluded to earlier, betalains are not the only antioxidant compounds present in beetroot. 
Beetroot contains several highly bioactive phenolics, such as rutin, epicatechin and caffeic acid which 
are also known to be excellent antioxidants [2,36,39]. Furthermore, nitrite and other NO donors akin to 
beetroot have been shown to suppress radical formation and directly scavenge potentially damaging RONS 
such as superoxide and hydrogen peroxide, suggesting nitrate may also exhibit antioxidant effects [19,52,53]. 
A number of studies report that beetroot, in the form of a juice supplement, protects against oxidative 
damage to DNA, lipid and protein structures in vitro [27,54,55]. A study by Wootton-Beard and Colleagues 
suggests that a key mechanism by which beetroot juice exerts its antioxidant effects is by scavenging 
radical species [56]. They found that two commercially available beetroot juices inhibited in vitro radical 
formation in the 2,2-diphenyl-1-picrylhydrazyl (DPPH•) and (3-ethylbenzothiazoline-6-sulfonicacid) 
ABTS• assays by 100% and 92%, respectively. Importantly, when these assays were repeated, but in 
conditions designed to simulate the human digestive process, the juices still retained ≥55% of their  
pre-digestion radical scavenging capacity. Furthermore, the antioxidant capacity of both drinks, as measured 
by ferric reducing antioxidant power (FRAP), was higher than the other 22 vegetable juice drinks under 
investigation. In another study [21], they showed that the FRAP of beetroot juice actually increases 
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following simulated digestion. This is probably a consequence of several compounds being structurally 
altered to secondary metabolites that possess antioxidant functions [21,56]. Further work from this group 
has shown that the antioxidant capacity of beetroot juice is comparable to or higher than a variety of fruit 
and vegetable juices (See Figures 2 and 3) [56,57]. Interestingly, the antioxidant capacity of beetroot juice 
in both the (DPPH•) and FRAP assays was far greater than more well-known vegetable juices, such as 
tomato and carrot, and fruit juices, such as orange and pineapple, with only pomegranate juice displaying 
a higher antioxidant capacity in the FRAP assay. 
 
Figure 2. A comparison of the 2,2-diphenyl-1-picrylhydrazyl (DPPH•) inhibiting capacity 
(%) exhibited by 10 popular fruit and vegetable beverages available in the UK (values based 
on data from [56,57]). 
 
Figure 3. The free radical antioxidant power (FRAP) of 10 commercially available fruit and 
vegetable beverages post a simulated in vitro model of human digestion (values based on 
data from [56,57]). 
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In addition to being a source of antioxidants in vitro, a growing body of evidence using animal models 
illustrates that beetroot exhibits radical scavenging ability in vivo (see Table 1). In a recent study [23], rats 
were provided with 1–3 mL∙kg∙bm−1 of a beetroot pomace extract for 7 days prior to being exposed to  
2 mL∙kg∙bm−1 of carbon-tetrachloride (CCl4), a well-established carcinogen and RONS generator. After 
CCI4 administration, liver homogenate was removed from rats pre-treated with the beetroot extracts and 
those acting as controls (i.e., CCl4 only). Rats treated with beetroot extracts expressed significantly lower 
levels of lipid peroxidation measured as thiobarbituric acid reactive substances (TBARS). Furthermore, the 
beetroot extracts appeared to maintain endogenous antioxidant activity (reduced glutathione, glutathione 
peroxidase and catalase enzymes) at normal cellular concentrations following the oxidative insult. This 
led the authors to speculate that in response to in vivo cellular attack, beetroot may exhibit indirect 
antioxidant effects that act to up regulate antioxidant defence mechanisms [23]. 
Similar antioxidant effects have also been reported with studies using beetroot juice. Providing rats 
beetroot juice (8 mL∙kg∙bm∙day−1) for 28 days was shown to attenuate lipid peroxidation, protein oxidation 
and DNA damage following xenobiotic induced liver injury [54]. In a more recent, rats were fed beetroot 
juice (8 mL∙kg∙bm∙day−1 for 28 days) and treated with the carcinogen 7,12-dimethylbenz[a]anthracene 
(DMBA) on day 27 and 28 of the beetroot juice-feeding period study [58]. Several markers of liver damage 
and inflammation were significantly increased following the DMBA treatment; however, these were 
markedly reduced in the rats pre-treated with beetroot juice compared to the control group that received 
water only (see Table 1). There were no differences in DNA damage between the groups. Intriguingly, rats 
given beetroot juice only (i.e., not treated with DMBA) exhibited increased activity of phase II detoxifying 
enzymes (GST and NQO1), which play an important role in endogenous antioxidant defense. 
The enhanced endogenous antioxidant activity in vivo, by beetroot is a consistent finding in the literature 
(see Table 1). According to recent in vitro data, such effects might be related, in part, to betanin and its 
effect on signalling pathways that mediate the transcription of antioxidant genes. Esatbeyoglu et al. [59] 
found that betanin (extracted from beetroot) dose dependently (5–15 μm) increased the activity of nuclear 
factor (erythroid-derived 2)-like 2 (Nrf2), a transcription factor that activates a gene promoter sequence: 
the antioxidant response element (ARE) responsible for the transcription of several endogenous antioxidant 
enzymes [59–61]. Krajka-Kuźniak et al. [62] presented similar findings, showing that betanin (2, 10 and 
20 μm concentration) activates the Nrf2-ARE binding sequence in non-tumor human hepatic cell lines. 
Furthermore, this led to increased activity and mRNA expression of several phase II detoxifying enzymes, 
including glutathione S-tranferases and NAD(P)H:quinone oxidoreductase, which play important roles 
in host defense against xenobiotics. This raises the possibility that beetroot’s antioxidant potential is not 
limited to just scavenging and suppressing RONS, but includes the ability to reinforce the endogenous 
antioxidant network; however, whether such effects translate in vivo, particularly in humans is yet to  
be investigated. 
Given these findings, it should also be considered that other compounds in beetroot (and their 
downstream metabolites upon ingestion) possess similar effects to betanin on transcriptional activity. Thus, 
in vivo, these compounds and metabolites could work synergistically to activate the NRF2-ARE pathway, 
which, in turn, mediates an increase in endogenous antioxidant activity. Such a possibility deserves 
further attention.  
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Table 1. Overview of human and animal studies investigating the effects of beetroot and its derivatives on oxidative stress and inflammation. 
Authors 
Cohort under 
Investigation 
Dosage  
Antioxidant Capacity 
of Treatment 
Duration Toxic inducing Protocol  Inflammation  Oxidative Stress 
Enzymatic 
Antioxidant Activity  
[54]  48 male  
wistar rats  
Beetroot juice delivered by gavage  
(8 mL∙kg∙bm∙day−1; ≈1.92 mL∙day−1) 
23.5 μmol Trolox 
equivalents∙mL−1 28 days 
Intraperitoneal injection of CCl4  
(2 mL∙kg∙bm−1) or NDEA  
(150 mL∙kg∙bm−1)  
N/A 
TBARS ↓  
PC ↓  
DNA damage ↓ 
SOD ↑  
GPX ↑  
CAT ↑  
GR ↑ 
[63]  80 male  
ICR mice 
Betalains from beetroot delivered orally  
(0, 5, 20 and 80 mg∙kg∙bm∙day−1;  
≈0–1.44 mg∙day−1) 
N/A 30 days 
Exposed to cobalt-60-γ-gamma 
radiation (6.0 Gy, 1.5 Gy min−1) N/A MDA ↓  
SOD ↑  
CAT ↑  
GSH ↑  
[64]  24 male  
wistar rats 
Beetroot juice delivered by gavage  
(8 mL∙kg∙bm∙day−1) N/A 28 days 
Intraperitoneal injection of NDEA  
(150 mL∙kg∙bm−1) 
LDH ↓  
AST ↓  
ALT ↓ 
DNA damage ↓ GST ↑ 
[27] 10 osteoarthritic 
patients  
Capsules made from beetroot  
extract delivered orally (70–200 mg∙day−1) N/A 10 days N/A 
TNF-α ↓  
IL-6 ↓  
RANTES ↓  
GRO-α ↓ 
AOPP ↓ N/A 
[23]  48 albino  
wistar rats  
Beetroot pomace extract delivered 
intraperitoneally (1–3 mL∙kg∙bm∙day−1;  
≈0.2–0.6 ml∙day−1) 
N/A 7 days 
Intraperitoneal injection of CCl4  
(2 mL∙kg∙bm−1) N/A MDA ↓ 
GSH ↑  
GSHPx ↑  
GR ↑  
CAT ↑  
[65]  24 albino wistar 
rats 
Extracts of fresh beetroot delivered orally  
(250 and 500 mg∙kg∙bm∙day−1;  
≈45–90 mg∙day−1) 
90.1% radical 
inhibition in the 
DPPH• assay  
(500 μg∙mL−1) 
28 days 
Intraperitoneal injection of 
gentamicin  
(8 mg∙kg∙bm−1 for 8 days) 
IL-6 ↓  
TNF-α ↓  
MPO ↓  
NF-κB ↓ 
MDA ↓
 
CAT ↑  
NP-SH ↑  
[58]  
24 female  
Sprague-dawley 
rats  
Beetroot juice delivered by gavage  
(8 mL∙kg∙bm∙day−1; ≈1.92 mL∙day−1) N/A 28 days 
Intraperitoneal injection of DMBA  
(10 mg∙kg∙bm−1 for 2 days) 
LDH ↓  
ALT↓ N/A 
GST ↑  
NQO1 ↑ 
NDEA, N-nitrosodiethylamine; GST, glutathione S-transferase; RANTES, regulated upon activation normal T cell growth; GRO-α, regulated oncogene-alpha; CCl4 carbon tetrachloride; GSH, reduced glutathione; GSHPx, glutathione 
peroxidase; GR, glutathione reductase; GPX, glutathione peroxidase; TNF-α, tumour necrosis factor-alpha; TBARS, thiobarbituric acid reactive species; PC, protein carbonyls; SOD, superoxide dismutase; ICR, imprinting control 
region; MDA, Malondialdehyde; CAT, catalase; AOPP, advanced oxidation protein products; IL-6, interleukin-6. Gy, gray unit; LDH, lactate dehydrogenase; ALT, alanine aminotransferase; AST, aspartate aminotransferase; MPO, 
myeloperoxidase. NF-κB, nuclear factor kappa B; NP-SH, non-protein sulfhydryl; DMBA, 7,12-dimethylbenz[a]anthracene; NQO1, NAD(P)H dehydrogenase [quinone] 1. 
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Collectively, the studies to date provide evidence that beetroot is an excellent source of antioxidants 
that protects cellular components from oxidation in vitro and importantly, in vivo. This would suggest that 
beetroot supplementation might be a promising adjunct strategy to help manage diseased states propagated 
by oxidative stress, such as liver injury and cancer. With that said, there is still a lack of well-conducted 
human trials, which precludes any definitive recommendations for its clinical use. Moreover, data is 
currently limited to paradigms inducing oxidative stress through exogenous pathways (i.e., xenobiotics) 
while endogenously generated RONS play a significant role in human disease [66]. In this respect, 
strenuous physical exercise could serve as a useful model to study the antioxidant potential of beetroot 
and its constituents in humans. There are several reports documenting that the mechanical and metabolic 
muscle damage sustained during intense exercise induces short-term oxidative stress, which can persist for 
several days until redox balance is restored [67,68]. Therefore, it should be considered that application of 
a beetroot preparation following an exercise task might serve as a useful model to give an insight into 
beetroot’s efficacy as an antioxidant agent in humans, and most importantly, provide a more in-depth 
understanding of its potential application in clinical settings.  
4. Inflammation  
Under normal circumstances, inflammation is regarded as a beneficial process, governing our innate 
response to biological or physical stimuli such as trauma, infection and other pathogens that may cause 
the organism harm and disrupt homeostasis [69–71]. With that said, immune activation may still have 
undesirable consequences for the host. In the short term, redness, swelling, pain and diminished function 
may be experienced at the site of inflammation; however, more concerning is the potential long-term 
implications if inflammation persists, and is unresolved [71,72]. Failure to remove the invading element 
and restore normal immune function can cause chronic inflammation resulting in long-term cell 
dysfunction [73]. Chronic inflammation is often implicated in the onset and progression of several 
clinical disorders such as obesity, liver disease, cancer and heart disease [69,74,75].  
Since the 1970’s, traditional treatment for inflammatory disorders has been non-steroidal  
anti-inflammatory drugs (NSAIDS) [71]. However, these drugs, particularly in chronic doses, may actually 
have deleterious consequences for health and evoke negative side effects [74,76]. Above all, they have 
been deemed ineffective in the treatment of many inflammatory related conditions [74]. Consequently, 
focus has shifted towards the anti-inflammatory effects of natural food sources and their potential use as 
alternatives to synthetic NSAID treatments [72].  
Betalains and beetroot extracts have emerged as potent anti-inflammatory agents. At least part of their 
anti-inflammatory effects seems to be mediated by interfering with pro-inflammatory signalling cascades 
and are summarised in Figure 4. The most important of these is the Nuclear Factor-Kappa B (NF-κB) cascade, 
as it directly activates and transcribes most gene targets that regulate and amplify the inflammatory response 
(i.e., cytokines, chemokines, apoptotic and phagocytic cells) [43]. Consequently, NF-κB activity plays a 
central role in the inflammatory processes that manifest in chronic disease [43]. In a recent study [65], NF-
κB DNA-binding activity was dose-dependently attenuated in nephrotoxic rats administered a beetroot 
extract for 28 days (250 mg or 500 mg∙kg∙bm−1). Furthermore, kidney homogenates from the beetroot 
treated rats had lower concentrations of immune cells (TNF-α, IL-6 and MPO) and reduced signs of 
oxidative damage (MDA), which could be directly related to the blunting of the NF-κB pathway. These 
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effects are likely to be mediated, at least in part, by the betalains present in beetroot; recent evidence shows 
that betanin treatment (25 and 100 mg∙kg∙bm−1 for 5 days) significantly inhibits NF-κB DNA-binding 
activity in rats induced with acute renal damage [77]. Betalains have also been shown to markedly supress 
cyclooxygenase-2 (COX-2) expression in vitro, which is an important precursor molecule for  
pro-inflammatory arachidonic acid metabolites known as prostaglandins [3,26,50]. Reddy et al. [50] 
who found that betanin (IC50 value 100 μg·mL−1) inhibited cyclooxygenase-2 (COX-2) enzyme activity 
by 97%, first illustrated this. It is interesting to note that although a slightly higher concentration of betanin 
was required, its COX-2 inhibitory effects were comparable or greater than several phenolic compounds 
(cyanidin-3-O-glucoside, lycopene, chlorophyll, b-carotene, and bixin) and anti-inflammatory drugs 
(Ibuprofen, Vioxx and Celebrex). This raises the possibility that betanin rich beetroot supplements, in 
sufficient doses, could exhibit anti-inflammatory effects to rival synthetic drugs. 
 
Figure 4. Illustration of the inflammatory cascade in response to cellular attack and  
possible pathways where betalains may exhibit inhibitory effects. PGF2, Prostaglandin F2; 
PGE2, Prostaglandin E2; COX ½, Cyclooxygenase 1 and 2; LOX, lipoxygenase; LOX-5,  
5-lipoxygenase; LOX-12, 12- lipoxygenase; HOCI, Hypochlorous acid; OH•, Hydroxyl 
radical; NF-κB, Nuclear Factor-Kappa B; AP-1, Activator protein 1; IL-6, Interleukin-6; IL-8, 
Interleukin-8; IL-1β, Interleukin-1 beta; TNF-α, tumour necrosis factor-alpha. 
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A recent study from Vidal et al. [26] provided further support for the anti-inflammatory effects of 
betalains. As well as supressing COX-2 synthesis, betanidin, extracted from beetroot, dose dependently 
inhibited (to 9% of control activity), lipoxygenase (LOX), a catalytic enzyme vital for the synthesis of 
pro-inflammatory leukotriene molecules [70]. Interestingly, these inhibitory effects appeared to be 
mediated by a blocking action on membrane binding activity, indicating that betalains target cell signalling 
pathways at the molecular level, acting in a similar fashion to selective COX-2 inhibitor drugs [26,70]. 
There are a limited number of studies demonstrating that beetroot supplements have anti-inflammatory 
effects in vivo. Pietrzkowski et al. [27] showed that therapeutic administration of betalain-rich oral 
capsules made from beetroot extracts alleviated inflammation and pain in osteoarthritic patients. After 
10 days of supplementation (100, 70 or 35 mg per day), the pro-inflammatory cytokines; tumour necrosis 
factor-alpha (TNF-α) and interleukin-6 (IL-6), had decreased from baseline by 8.3%–35% and 22%–28.3%, 
respectively. The activity of two chemokines; regulated oncogene-alpha (GRO-alpha) and regulated 
upon activation normal T cell growth (RANTES) were also markedly inhibited by the beetroot treatment. 
Furthermore, the moderated inflammatory response coincided with a significant reduction in self-reported 
pain on the McGill Pain Questionnaire. Krajka-Kuźniak et al. [64] examined the protective effect of 
beetroot juice (8 mL∙kg∙bm∙day−1 for 28 days) on markers of liver injury and inflammation induced by the 
toxic chemical N-nitrosodiethylamine (NDEA) in rats. Compared to an untreated control, the beetroot juice 
conferred significant hepatic protection against a range of inflammatory markers induced by NDEA 
administration; lactate dehydrogenase, aspartate aminotransferase, gamma glutamyl transferase and alanine 
aminotransferase were all shown to be markedly attenuated. In a more recent study, El Gamal et al. [65] 
fed rats either water (control) or oral doses of beetroot ethanol extract (250 or 500 mg∙kg∙bm∙day−1) for 
28 days; from day 20–28 they were treated with the nephrotoxic drug gentamicin (85 mg∙kg∙bm∙day−1). 
After 28 days, kidney homogenates were removed from both groups and analysed for several markers of 
renal damage. They found that the beetroot-treated rats had significantly lower concentrations of several 
pro-inflammatory mediators, including Il-6, TNF-α, myeloperoxidase (representing neutrophil infiltration) 
and the transcription factor NF-κB. They also found reduced oxidative stress (MDA, uric acid) and 
increased endogenous antioxidant activity (CAT, non protein sulfhydryl; NP-SH) in the homogenates 
removed from the rats pre-treated with beetroot. Taken together, these studies support the notion that 
beetroot supplementation offers anti-inflammatory protection in vivo; however, well designed, long-term 
clinical trials are clearly required to elucidate whether such a strategy would assist in the management 
of inflammatory-related disorders. 
The antioxidant and anti-inflammatory activity of beetroot has also led to interest in its potential use 
in diseases characterized by aberrant immune cell function. Indeed, chronic inflammation is increasingly 
being implicated in the development of malignant tumours and evidence is accumulating to suggest 
betalain extracts obtained from beetroot may suppress these effects. For instance, Lechener et al. [78] 
examined whether long term (35 weeks) treatment with a betacyanin containing extract (78 μg∙mL∙day−1 
of E162, red food colour prepared from beetroot) would inhibit tumour incidence in rats exposed to a 
potent tumour promoter (N-nitrosomethylbenzylamine). In comparison to control, the beetroot extracts 
markedly inhibited cell proliferation, angiogenesis and tumorgenesis in oesophageal lesions, effects largely 
attributed to its radical scavenging and anti-inflammatory activity. This was evidenced by the significantly 
reduced number of inflammatory lymphocytes present in the oesophageal tumours of the beetroot-treated 
rats only. The chemo-preventive effects of betacyanin extracts have also been observed in lung, skin and 
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liver cancer cells in animal models, and recently, in human prostate, skin, breast and pancreatic tumour 
cells [28–31]. Furthermore, co-administration of beetroot extracts with doxorubicin, an effective but highly 
toxic chemotherapy drug, significantly reduces its cytotoxicity, probably by modulating the drug’s 
induction of tumour promoting RONS [28,31]. Although far from conclusive, these initial findings in 
animal and human cell lines suggest beetroot supplementation holds promise as a future strategy to at least 
help manage some of the symptoms of inflammation in cancer.  
5. Endothelial Function  
As described earlier, nitrate delivered via a beetroot source is metabolised to nitrite, which can be further 
reduced to produce NO [4,13]. The conversion of nitrite to NO can be catalysed by a number of molecules 
with reductase potential (i.e., electron donors), and to date, several proteins (i.e., deoxymyoglobin, xanthine 
oxioreducatse) and antioxidants (i.e., vitamin C) have been reported to facilitate this reduction [4,79,80]. 
One of the most important functions of endogenous NO is to maintain endothelial function [13,81]. The 
endothelium plays a critical role in the regulation of vascular homeostasis by maintaining thrombotic 
activity, platelet function, vascular tone and the delicate balance between the release of vasodilating (i.e., 
NO, prostacyclin) and vasoconstricting agents (i.e., endothelin-1, thromboxane) [81,82]. Because NO 
mediates many of the endothelium’s functions, a depletion in NO availability, as seen with aging, has been 
singled out as the principal cause of endothelial dysfunction [81]. Endothelial dysfunction is proposed 
as a primary risk factor for several cardiovascular disorders and has been implicated in the pathogenesis 
of hypertension and atherosclerosis [16,83]. Therefore, beetroot, as a natural NO donor, has been explored 
as a nutritional approach to preserve or restore endothelial function.  
Webb et al. [10] were the first to investigate the effects of a beetroot supplement on endothelial function 
in healthy participants. They measured brachial artery (BA) endothelial function using the flow mediated 
dilation technique (FMD), which involved calculating BA dilation before and after a 20 min ischemic insult. 
The ischemic procedure (BA occlusion) was effective at inducing endothelial dysfunction, as evidenced 
by the 60% decrease from pre to post BAFMD response. However, when participants were pre-treated 
2 h prior with a single serving of beetroot juice (500 mL; 23 mmol of nitrate) the BAFMD response was 
maintained at pre-ischemic levels, suggesting that beetroot juice acted to preserve endothelial function. 
Hobbs et al. [12] extended these findings, examining the acute intake of a novel beetroot enriched bread 
(100 g beetroot, nitrate; 1.1 mmol) on micro vascular function and peripheral arterial stiffness in young 
healthy males. Although arterial stiffness, assessed by pulse wave velocity and augmentation index, was 
unaffected by the intervention, the beetroot bread increased micro vascular vasodilation, as measured by 
changes in cutaneous perfusion using laser doppler imaging (LDI). Endothelium-independent vasodilation 
(perfusion units) was ~343% greater in the 6 h after ingesting the beetroot enriched bread compared to the 
control bread. Importantly, this study provided evidence that even a small nitrate load (1.1 mmol) can 
augment marked improvements in intravascular function. Similar vascular effects were also reported in a 
study with older populations. Using apparently healthy but slightly obese, older participants (~61 years), 
Joris and Mensink, [83] investigated whether beetroot juice supplementation would prevent postprandial 
impairments in BAFMD. In a randomized crossover design, BAFMD response fell by ~1.6% in the 
control condition, whereas after beetroot juice (140 mL, nitrate; 500 mg) the impairment was only ~0.4%, 
indicative of a beetroot-mediated protective effect on postprandial endothelial function. 
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Replicating the aforementioned findings in volunteers with an increased risk of endothelial dysfunction 
has proved more difficult. For instance, Kenjale et al. [84] reported that acute beetroot juice intake (500 mL) 
had no influence on endothelial function in peripheral arterial disease (PAD) patients, as assessed by 
BAFMD response (% arterial dilation) to a hyperaemic stimulus. In another study, type 2 diabetic volunteers 
were given either beetroot juice (250 mL·day−1; nitrate: 7.5 mmol) or a nitrate depleted placebo but otherwise 
nutritionally matched beetroot juice for 14 days [85]. After the treatment period, BAFMD response was 
similar between control and beetroot juice groups (4.94% vs. 4.97% change in vessel diameter, respectively) 
and no differences in micro vascular vasodilation, as measured by LDI, could be detected between the 
two conditions. However, perhaps the lack of an effect in these studies is not surprising, given that unlike 
the studies with healthy cohorts, most volunteers were already receiving vasoactive medications for their 
respective conditions. It is conceivable that these medications diminished or confounded any potential 
vascular response afforded by nitrate. Perhaps a more profound response to beetroot supplementation could 
be elicited in pre-clinical patients, i.e., those not yet requiring prescription medications that interfere with 
vascular function. An alternative explanation for the findings in the latter study is that bioactive 
constituents (i.e., betalains, caffeic acid) other than nitrate (likely present in both the nitrate depleted 
placebo and nitrate rich beetroot juice) could have mediated a dilatory response. Indeed, there is evidence 
that other antioxidants such as flavonoids possess dilatrory effects in humans [86]. If betalains or indeed 
other antioxidants present in beetroot exerted similar effects in this study then BAFMD and micro 
vascular function would not be expected to differ between the two conditions. However, the dilatory 
effects of these compounds and consequences for endothelial function are yet to be investigated and 
therefore such an effect can only be speculated at present.  
It is also important to note that several disease states, including type 2 diabetes, are characterised by 
persistent inflammation and an excess production of RONS [87,88]. This could limit the efficacy of 
nitrate supplementation, because RONS such as superoxide (O2-) directly react with NO, diminishing its 
bioavailability [85]. Therefore, any benefits of the surplus NO generated by ingesting dietary nitrate could 
be reduced in the presence of oxidative stress. To counter this, perhaps these pathologies would benefit 
from higher doses of beetroot juice, not only to increase the amount of ingested nitrate (and NO generation) 
but also to provide a stronger antioxidant defence (i.e., betalains) against RONS. Such an approach might 
help enhance nitrate mediated NO bioavailability. Further research is required to establish the role of 
beetroot supplementation in endothelial dysfunction.  
6. Cognitive Function 
Cognitive function deteriorates with age and one of the key pathological events that precedes its 
development is reduced cerebral blood flow [89–91]. Indeed, an age related decrease or impairment in 
cerebral perfusion has been implicated in several neurological disorders associated with poor cognitive 
ability, such as brain damage, clinical dementia and Alzheimer’s disease [92,93]. One of the major triggers 
and risk factors for the onset and development of cerebral hypo-perfusion is a disruption in neurovascular 
function; an effect that is, in part, mediated by impaired NO activity [92,93]. A diminished capacity to 
generate NO can impair the normal function of cerebral energy metabolism (i.e., glucose delivery) and 
neuronal activity (i.e., cellular communication), which over a chronic period might induce neurodegeneration 
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and cognitive deficits [90–92]. Therefore, it is conceivable that a NO generator like beetroot has the 
potential to improve cerebrovascular blood flow and challenge detriments in cognitive function. 
Two recent human studies examined the influence of dietary nitrate on cerebral blood flow.  
Presley et al. [6] measured cerebral perfusion after providing a group of older adults (~75 years) a high 
nitrate diet (~12 mmol) including beetroot juice, or a nitrate depleted diet (~0.09 mmol) for 24 h. Magnetic 
resonance imaging (MRI) revealed that the high nitrate diet stimulated a substantial and preferential 
increase in frontal cortex perfusion, a region of the brain responsible for essential cognitive processes such 
as executive function, working memory and task-switching. Further work by Bond et al. [89] supports 
these conclusions, showing a decrease in cerebrovascular arterial resistance (indicative of increased 
cerebral blood flow) following a single serving of nitrate rich beetroot juice (500 mL). However, it is 
important to note that the subjects in this study were young (~21 years), asymptomatic and apparently 
disease-free, limiting the application of these findings in elderly and diseased populations.  
Although long-term clinical trials are yet to be conducted, two recent preliminary studies explored 
the influence of acute beetroot supplementation on age-related cognitive function. In one of these studies, 
older (~67 years), type 2 diabetics, supplemented with 250 mL of beetroot juice (nitrate: 7.5 mmol) for 
14 days, experienced a significant improvement in simple reaction time compared to a control group [5]. 
However, no effects were evident in other cognitive tests associated with decision-making, rapid processing, 
shape and spatial memory [5]. Another study from the same group [94] investigated the effects of a 
beetroot juice supplement (140 mL·day−1: nitrate: 9.6 mmol) on cognitive function in healthy, older adults 
(~63 years). After 3 days of supplementation, they failed to detect any changes in cognitive performance 
for concentration, memory, attention and information processing ability between the beetroot juice and 
control condition. Furthermore, a range of brain metabolites associated with neuronal functioning (N-
acetylaspartate, creatine, choline and myo-Inositol) were not, as hypothesized, upregulated after taking 
beetroot juice. The somewhat contrasting results between these two studies may be partly explained by 
differences in participant cohort (type 2 diabetics vs. healthy older adults), cognitive tests employed 
(Kelly et al. [94] did not use a simple reaction time test) and dose duration. With regards to the latter posit, 
perhaps the cerebrovascular response required to elicit measurable changes in cognitive function can only 
be achieved with longer term dosing strategies that have the potential to induce sustained modifications to 
cerebrovascular function [94]. Nonetheless, the beetroot-mediated increases in simple reaction time reported 
by Gilchrist et al. [5] is worthy of further investigation, given the potential benefits for clinical populations. 
A recent addition to the literature investigated whether acute beetroot juice supplementation could 
augment cerebral oxygenation status and subsequently aid cognition during a fatiguing exercise task [95]. 
Beetroot juice (500 mL, nitrate: 5 mmol) ingested 90 min before exercise reduced cerebral deoxygenation 
status, as measured by near infrared spectroscopy, but failed to improve reaction time and information 
processing at rest, while cycling at 50%, 70% and 90% of VO2 peak and upon completion of the exercise 
task. As with the previously mentioned study [94], a single serving of beetroot juice may not have been 
sufficient to induce measurable changes in cognitive performance. This is the only study that has examined 
beetroot in this fashion; consequently, there is scope for further research to investigate the potential role 
of beetroot juice in cognitive function at rest and during exercise.  
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7. Conclusions 
Based on the available data, beetroot appears to be a powerful dietary source of health promoting agents 
that holds potential as therapeutic treatment for several pathological disorders. The powerful antioxidant, 
anti-inflammatory and vascular-protective effects offered by beetroot and its constituents have been clearly 
demonstrated by several in vitro and in vivo human and animal studies; hence its increasing popularity as 
a nutritional approach to help manage cardiovascular disease and cancer. In the human studies to date, 
beetroot supplementation has been reported to reduce blood pressure, attenuate inflammation, avert oxidative 
stress, preserve endothelial function and restore cerebrovascular haemodynamics. Furthermore, although 
beyond the scope of this review, several studies have now established beetroot supplementation as an 
effective means of enhancing athletic performance [96,97].  
8. Future Directions  
While the precise mechanisms by which beetroot exerts these beneficial effects are yet to be fully 
elucidated, the present status quo dictates that the cardio-protective, physiological and metabolic effects are 
mediated by nitrate and its subsequent conversion to NO, while the anti-oxidative and anti-inflammatory 
effects are mediated by betalains and other phenolics. However, it is important to recognise that the relative 
contribution of each compound is far more complex and that additive and synergistic effects cannot be 
ruled out.  
The present data indicates that the bioactive constituents in beetroot, especially nitrate, appear to be 
well absorbed and bioavailable in humans. While an optimal dosing strategy does not currently exist, the 
available data suggests that the multitude of beneficial health effects offered by beetroot can be realised 
with amounts easily achievable in the diet or with a supplement such as beetroot juice; although at present, 
there is insufficient evidence regarding the efficacy, and above all, safety of beetroot supplementation 
to recommend a long-term strategy. Indeed, potentially detrimental health effects arising from excessive 
intake of beetroot and supplemental derivatives have not been adequately explored. The historical belief 
that nitrite is a carcinogenic substance in humans still reverberates and concerns have been raised over 
the uncontrolled use or excessive intake of nitrate rich substances [98,99]. However, natural beetroot 
juice supplements, as opposed to sodium nitrite salts for instance, are unlikely to pose a significant health 
risk, at least in the short term [99,100]. While there is presently no anticipated negative health outcomes 
associated with other constituents of beetroot, consumers should be aware that some supplements (i.e., 
juices) could have a relatively high sugar content, which might need to be taken into consideration by 
some individuals (i.e., diabetics). Future studies are still required to evaluate the long term safety of a 
dietary beetroot intervention particularly in clinical settings. In this respect, beetroot supplementation could 
be easily administered, and of course, there would be economic and practical benefits of such an approach. 
A variety of beetroot based supplements including juices and capsules are now widely available and 
relatively inexpensive, particularly in comparison to synthetically manufactured drugs. It is therefore 
critical that future studies focus on the long-term effects (≥4 weeks) of beetroot supplementation. 
Although the results so far are promising, most studies tend to use healthy cohorts as participants which 
limit the applicability of their findings to clinical populations. Furthermore, the overwhelming majority of 
human studies have focused on the ergogenic or cardio-protective effects of beetroot supplementation, while 
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little attention has been given to the potential anti-oxidative and anti-inflammatory effects. Consequently, 
there is a great deal of scope to explore the influence of beetroot supplementation in human disorders 
characterised by chronic inflammation and oxidative stress (i.e., cancers, arthritis, inflammatory bowel 
disease etc.). 
Nevertheless, beetroot supplementation is a new and exciting area of research that to date has been 
shown to induce favourable effects in several facets of health and disease. This indicates that beetroot 
supplementation holds promise as an economic, practical and importantly natural dietary intervention in 
clinical settings. Because of beetroot’s high biological activity, there are still several unexplored areas in 
which supplementation might confer health benefits. This includes but is not limited to; pain reduction, 
cognitive function, vascular function, insulin resistance, cancer and inflammation, especially in older and 
diseased populations. 
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